Daiwa Securities Group Inc. Sells 6,055 Shares of Intuitive Surgical, Inc. $ISRG

Daiwa Securities Group Inc. lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.0% in the second quarter, HoldingsChannel.com reports. The fund owned 95,479 shares of the medical equipment provider’s stock after selling 6,055 shares during the period. Daiwa Securities Group Inc.’s holdings in Intuitive Surgical were worth $51,884,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. L2 Asset Management LLC raised its holdings in shares of Intuitive Surgical by 4.8% in the 2nd quarter. L2 Asset Management LLC now owns 1,601 shares of the medical equipment provider’s stock valued at $870,000 after purchasing an additional 73 shares during the period. Vertex Planning Partners LLC raised its stake in Intuitive Surgical by 2.3% in the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after buying an additional 21 shares during the period. Winslow Capital Management LLC lifted its position in shares of Intuitive Surgical by 20.2% in the second quarter. Winslow Capital Management LLC now owns 1,342,473 shares of the medical equipment provider’s stock valued at $729,513,000 after buying an additional 225,545 shares during the last quarter. Howard Hughes Medical Institute bought a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $42,000. Finally, Natixis increased its holdings in shares of Intuitive Surgical by 30.7% during the 2nd quarter. Natixis now owns 120,254 shares of the medical equipment provider’s stock worth $65,347,000 after acquiring an additional 28,274 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 22,806 shares of the firm’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $570.89, for a total value of $13,019,717.34. Following the transaction, the insider owned 2,694 shares in the company, valued at approximately $1,537,977.66. This trade represents a 89.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 105 shares of the business’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $560.00, for a total value of $58,800.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 108,939 shares of company stock worth $60,757,995 in the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 1.5%

Shares of NASDAQ:ISRG opened at $566.89 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company’s 50 day moving average price is $521.15 and its two-hundred day moving average price is $505.21. The firm has a market cap of $203.22 billion, a PE ratio of 74.99, a PEG ratio of 5.29 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.84 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on ISRG. Mizuho set a $575.00 price target on Intuitive Surgical in a research note on Wednesday, October 22nd. Sanford C. Bernstein restated an “outperform” rating and set a $685.00 target price on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday. HSBC increased their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $607.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.